Renerve Limited has released a press release.
ReNerve - Q3 FY25 Activities Report & Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Renerve
- Expands Global Footprint with Strategic Partnership in India
- Response to ASX Aware Letter
- Clinical Outcome Demonstrates Material Benefits for Patients
- 1HFY25 Results Announcement
- 1HFY25 Appendix 4D and Half Year Report
Later from Renerve
- ReNerve receives market approval in Bahrain
- Expands Product Portfolio with Berkley partnership / Webinar
- Q4 FY25 Activities Report and Appendix 4C
- ReNerve records first sale of deep dermal product range
- ReNerve - Appendix 4E
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve